|
🐜
|
American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management
34 auth.
G. Raghu,
H. Collard,
J. Egan,
F. Martinez,
J. Behr,
K. Brown,
T. Colby,
Jean-Franc,
ois Cordier,
K. Flaherty,
J. Lasky,
D. Lynch,
J. Ryu,
J. Swigris,
A. Wells,
...
J. Ancochea,
D. Bouros,
Carlos R. Carvalho,
U. Costabel,
M. Ebina,
D. Hansell,
T. Johkoh,
D. S. Kim,
T. King,
Y. Kondoh,
J. Myers,
N. Müller,
A. Nicholson,
L. Richeldi,
M. Selman,
R. Dudden,
Barbara Griss,
Shandra L. Protzko,
H. Schünemann
|
12 |
2011 |
12
🐜
|
|
🐜
|
American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
83 auth.
W. Travis,
T. King,
E. Bateman,
D. Lynch,
Frédrique Capron,
T. Colby,
J. Cordier,
R. Dubois,
J. Galvin,
P. Grenier,
D. Hansell,
G. Hunninghake,
M. Kitaichi,
N. Müller,
J. Myers,
...
S. Nagai,
A. Nicholson,
G. Raghu,
B. Wallaert,
C. Brambilla,
K. Brown,
Andrew L. Cherniaev,
U. Costabel,
D. Coultas,
Gerald S. Davis,
M. Demedts,
W. W. Douglas,
J. Egan,
A. Eklund,
Leonarda M. Fabbri,
C. Henke,
R. Hubbard,
Y. Inoue,
T. Izumi,
H. Jansen,
I. D. Johnston,
D. S. Kim,
N. Khalil,
F. Lake,
G. Lungarella,
J. Lynch,
D. Mapel,
Fernando J. Martinez,
R. Matthay,
L. Newman,
P. Noble,
Ken Ohta,
D. Olivieri,
L. Ortiz,
V. Poletti,
R. Rodríguez-Roisín,
W. Rom,
J. Ryu,
P. Saldiva,
R. Sansores,
Marvin Schwarz,
M. Selman,
Cecelia M. Smith,
Z. Tong,
Z. Udwadia,
D. Valeyre,
A. Wells,
R. Wise,
A. Xaubet,
E. A. Fernández,
E. Brambilla,
V. Capelozzi,
Andrew L. Cherniaev,
P. Dalquen,
G. Dekan,
P. Hasleton,
J. Hogg,
N. Jambhekar,
A. Katzenstein,
M. Koss,
O. Matsubara,
K. Müller,
F. Thunnissen,
J. Waldron,
Wei Hua Li,
P. Friedman,
M. Rémy-Jardin,
T. McLoud
|
11 |
2002 |
11
🐜
|
|
🐜
|
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
36 auth.
W. Travis,
U. Costabel,
D. Hansell,
T. King,
D. Lynch,
A. Nicholson,
C. Ryerson,
J. Ryu,
M. Selman,
A. Wells,
J. Behr,
D. Bouros,
K. Brown,
T. Colby,
H. Collard,
...
C. Cordeiro,
V. Cottin,
B. Crestani,
M. Drent,
R. Dudden,
J. Egan,
K. Flaherty,
C. Hogaboam,
Y. Inoue,
T. Johkoh,
D. S. Kim,
M. Kitaichi,
J. Loyd,
Fernando J. Martinez,
J. Myers,
Shandra L. Protzko,
G. Raghu,
L. Richeldi,
N. Sverzellati,
J. Swigris,
D. Valeyre
|
11 |
2013 |
11
🐜
|
|
🦁
|
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
17 auth.
T. King,
W. Bradford,
S. Castro-Bernardini,
E. Fagan,
I. Glaspole,
M. Glassberg,
E. Gorina,
P. Hopkins,
D. Kardatzke,
L. Lancaster,
...
D. Lederer,
S. Nathan,
C. Pereira,
S. Sahn,
R. Sussman,
J. Swigris,
P. Noble
|
10 |
2014 |
10
🦁
|
|
🐜
|
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
12 auth.
P. Noble,
C. Albera,
W. Bradford,
U. Costabel,
M. Glassberg,
D. Kardatzke,
...
T. King,
L. Lancaster,
S. Sahn,
J. Szwarcberg,
D. Valeyre,
R. Bois
|
10 |
2011 |
10
🐜
|
|
🐬
|
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
Moiss Selman,
T. King,
A. Pardo
|
10 |
2001 |
10
🐬
|
|
🐢
|
Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
B. Ley,
H. Collard,
T. King
|
10 |
2011 |
10
🐢
|
|
🐬
|
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
G. Raghu,
K. Anstrom,
T. King,
J. Lasky,
F. Martinez
|
10 |
2012 |
10
🐬
|
|
🦁
|
Idiopathic pulmonary fibrosis
T. King,
A. Pardo,
M. Selman
|
10 |
2011 |
10
🦁
|
|
🐜
|
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
12 auth.
B. Ley,
C. Ryerson,
E. Vittinghoff,
J. Ryu,
S. Tomassetti,
Joyce S. Lee,
...
V. Poletti,
M. Buccioli,
B. Elicker,
K. Jones,
T. King,
H. Collard
|
10 |
2012 |
10
🐜
|
|
🦁
|
Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.
T. King,
J. Tooze,
M. Schwarz,
K. R. Brown,
R. Cherniack
|
9 |
2001 |
9
🦁
|
|
🐬
|
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.
H. Collard,
T. King,
B. B. Bartelson,
J. Vourlekis,
M. Schwarz,
K. Brown
|
9 |
2003 |
9
🐬
|
|
🦁
|
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis.
11 auth.
T. King,
K. Brown,
G. Raghu,
R. D. du Bois,
D. Lynch,
F. Martinez,
...
D. Valeyre,
I. Leconte,
A. Morganti,
S. Roux,
J. Behr
|
9 |
2011 |
9
🦁
|
|
🦁
|
Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality.
9 auth.
T. King,
M. Schwarz,
K. Brown,
J. Tooze,
T. Colby,
J. Waldron,
...
A. Flint,
W. Thurlbeck,
R. Cherniack
|
9 |
2001 |
9
🦁
|
